Who
Roger P. Deschenes
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Tecogen; Chief Financial Officer, Implant Sciences.
In numbers
- Trades disclosed
- 22
- Buys
- 1
- Sells
- 0
- Bought
- $45K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 7 Sep 2012
- Last trade
- 26 Jun 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 8 Sep 2026 | TGEN TecogenMachinery | SEC FORM 4 Code A | —29,013 at $0.00 | filing |
| 26 Jun 2026filed 8 Sep 2026 | TGEN TecogenMachinery | SEC FORM 4 Code A | —29,013 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | TGEN TecogenMachinery | SEC FORM 4 Code A | —29,013 | filing |
| 26 Jun 2026filed 30 Jun 2026 | TGEN TecogenMachinery | SEC FORM 4 Code A | —29,013 | filing |
| 20 Mar 2026filed 23 Mar 2026 | TGEN TecogenMachinery | SEC FORM 4 Bought | $22K10,000 at $2.23 | filing |
| 20 Mar 2026filed 23 Mar 2026 | TGEN TecogenMachinery | SEC FORM 4 Bought | $22K10,000 at $2.23 | filing |
| 24 Jul 2025filed 28 Jul 2025 | TGEN Tecogenoption or derivative · Machinery | SEC FORM 4 Code A | $101K12,063 at $8.35 | filing |
| 24 Jul 2025filed 28 Jul 2025 | TGEN TecogenMachinery | SEC FORM 4 Code A | —17,964 at $0.00 | filing |
| 2 Jul 2014filed 3 Jul 2014 | Implant Sciencesoption or derivative | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 6 Mar 2014filed 10 Mar 2014 | Implant Sciencesoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 13 Aug 2013filed 15 Aug 2013 | Implant Sciencesoption or derivative | SEC FORM 4 Code A | —141,502 at $0.00 | filing |
| 28 Nov 2012filed 30 Nov 2012 | Implant Sciencesoption or derivative | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 28 Nov 2012filed 30 Nov 2012 | Implant Sciences | SEC FORM 4 Code M | $10K100,000 at $0.10 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciencesoption or derivative | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciencesoption or derivative | SEC FORM 4 Code M | —75,000 at $0.00 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciences | SEC FORM 4 Code M | $5,00025,000 at $0.20 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciences | SEC FORM 4 Code M | $13K75,000 at $0.17 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciencesoption or derivative | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciencesoption or derivative | SEC FORM 4 Code M | —75,000 at $0.00 | filing |
| 20 Nov 2012filed 21 Nov 2012 | Implant Sciences | SEC FORM 4 Code M | $5,00025,000 at $0.20 | filing |
News
Tecogen, Inc.: Data Center Cuts Electric Bills Substantially with Tecogen's InVerdeTGEN · finanznachrichten.de · 14 Oct 2026
0 headlines in the last 90 days name Roger P. Deschenes; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.